Search
for

    Sort by

    Research 121–150 of 1000+

    1. Dermatologic Side Effects of Systemic Targeted Anticancer Therapy Springer eBooks · 2018
    2. JAK inhibitors in dermatology: The promise of a new drug class Journal of the American Academy of Dermatology · 2017 · 355 citations
    3. Emerging Topical and Systemic JAK Inhibitors in Dermatology Frontiers in Immunology · 2019 · 277 citations
    4. Alopecia Areata: a Comprehensive Review of Pathogenesis and Management Clinical Reviews in Allergy & Immunology · 2017 · 99 citations
    5. Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer Journal of the American Academy of Dermatology · 2014 · 88 citations
    6. Ovarian leukocyte distribution and cytokine/chemokine mRNA expression in follicular fluid cells in women with polycystic ovary syndrome Human Reproduction · 2006 · 69 citations
    7. Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease Alimentary Pharmacology & Therapeutics · 2013 · 60 citations
    8. Advances in the Management of Cutaneous Toxicities of Targeted Therapies Seminars in Oncology · 2012 · 42 citations
    9. A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata Clinical, cosmetic and investigational dermatology · 2021 · 40 citations
    10. Treatment options for alopecia: an update, looking to the future Expert Opinion on Pharmacotherapy · 2012 · 35 citations
    11. Inhibitory effect of M50054, a novel inhibitor of apoptosis, on anti-Fas-antibody-induced hepatitis and chemotherapy-induced alopecia European Journal of Pharmacology · 2001 · 28 citations
    12. New drugs under investigation for the treatment of alopecias Expert Opinion on Investigational Drugs · 2019 · 26 citations
    13. Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology Clinical & Translational Oncology · 2018 · 26 citations
    14. Novel therapies for alopecia areata: The era of rational drug development The Journal of Allergy and Clinical Immunology · 2017 · 9 citations
    15. A Real‐World Disproportionality Analysis of Avacopan in Anti‐Neutrophil Cytoplasmic Antibodies Associated Vasculitis: Insights From FDA Adverse Event Reporting System Pharmacology Research & Perspectives · 2025 · 2 citations
    16. Cepharanthine inhibits enterovirus entry by endolysosomal deacidification and exhibits protective activity <i>in vivo</i> Antimicrobial Agents and Chemotherapy · 2025 · 2 citations
    17. Evidence of a Causal Relationship Between Body Mass Index and Immune-Mediated and Inflammatory Skin Diseases and Biomarkers: A Mendelian Randomization Study Clinical Cosmetic and Investigational Dermatology · 2024 · 2 citations
    18. Primary cicatricial alopecias Expert Review of Dermatology · 2010 · 1 citations
    19. Role of neurosteroids in ischemic postconditioning-induced attenuation of cerebral ischemia-evoked neuronal injury and behavioral deficits in mice Der pharmacia lettre · 2015 · 1 citations
    20. Clinical Perspectives on Alopecia: From Hair Follicle Biology to Advanced Therapies International Journal of Drug Delivery Technology · 2026
    21. Tangled Causes, Targeted Solutions: A Comprehensive Review of Alopecia. International Journal of All Research Education & Scientific Methods · 2026
    22. Hair follicle stem cells and the collapse of self-tolerance in alopecia: the interplay of barrier function, the microbiome, and immunity EMBO Molecular Medicine · 2024
    23. Psoriasis del cuero cabelludo etiología, diagnóstico y tratamiento Polo del Conocimiento · 2024
    24. Alopecia Universalis Treated With Tofacitinib: The Role of JAK/STAT Inhibitors in Hair Regrowth Cutis · 2023
    25. PRIDE syndrome with lumbosacral hypertrichosis Dermatology Review · 2022
    26. Clinical features of 109 patients with primary cicatricial alopecia: a 15-year retrospective study Acta Dermatovenerologica Alpina Pannonica et Adriatica · 2026
    27. Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1) Journal of the American Academy of Dermatology · 2024 · 63 citations
    28. 17β-Estradiol Inhibits Wound Healing in Male Mice via Estrogen Receptor-α American Journal Of Pathology · 2010 · 38 citations
    29. Cutaneous manifestations associated with immune checkpoint inhibitors Frontiers in immunology · 2023 · 14 citations
    30. Cutaneous drug reactions Elsevier eBooks · 2010 · 1 citations